Clinical Trial Update: Pilot Study of Imatinib Cetuximab Combo for H & N Cancer [EARLY_Phase 1]

View source ↗

Summary

A pilot early-phase trial evaluating the combination of imatinib and cetuximab for head and neck cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Cetuximab (cetuximab)
• Imatinib (imatinib)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING